Home

Timothy Van Hauwermeiren

CIK 1816206 · last filed 2026-06-29

Timothy Van Hauwermeiren is a corporate insider who has filed 14 SEC Form 4 insider transactions across 4 companies since 2020. The most recent filing, for LXEO, was dated Jun 29, 2026. Current disclosed insider exposure totals $411.7K across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$411.7K

Companies

4

Total Filings

14

Lifetime Open-Market Net

$0

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
LXEO Director — $4.32 — $0 3 2026-06-29
DNLI Director 17,040 $24.16 $411.7K $0 2 2026-06-05
iTeos Therapeutics, Inc. (ITOS) Delisted Director 22,346 $10.15 $226.8K $0 7 2025-05-14
RayzeBio, Inc. (RYZB) Delisted Director — $62.49 — $0 2 2024-02-27

Recent Filings

14 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-29 LXEO Grant (A) — $0 EDGAR
2026-06-05 DNLI Grant (A) +6,408 $0 EDGAR
2025-11-06 DNLI Grant (A) +10,632 $0 EDGAR
2025-06-30 LXEO Grant (A) — $0 EDGAR
2025-05-14 iTeos Therapeutics, Inc. (ITOS) Delisted Exer (M) +22,346 $96.1K EDGAR
2024-07-08 LXEO Grant (A) — $0 EDGAR
2024-06-13 iTeos Therapeutics, Inc. (ITOS) Delisted Grant (A) — $0 EDGAR
2024-02-27 RayzeBio, Inc. (RYZB) Delisted Disp (D) — $0 EDGAR
2023-11-01 RayzeBio, Inc. (RYZB) Delisted Grant (A) — $0 EDGAR
2023-06-15 iTeos Therapeutics, Inc. (ITOS) Delisted Grant (A) — $0 EDGAR
Showing 1–10 of 14
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.